IMAGINT research consortium, also an FP7 project, aims to develop new tools for imaging the « HER » family of tyrosine kinase cell surface receptors and their interactions in breast cancer. University College of London, Kings College of London, Universities of Zurich and Uppsala are only a few of Firalis partners in the project (for Firalis’ role in the project, please click here). To view the complete list of partners and for more information on Imagint, visit project’s public web-site: